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Introduction
With the improvements in medical treatment and ageing 
populations, the number of cancer survivors is increasing 
worldwide [1, 2]. Cancer survivors are vulnerable to suffer-
ing from second cancer and comorbid chronic conditions 
with advanced age [3, 4]. Historically, most cancer patients 
were followed up by hospital specialists [5, 6]. However, 
Nielsen et al. [7] believes that most cancer patient might 
feel left alone after they are discharged from the hospi-
tal. Besides, Yang et al. [8] argues that cancer specialists 
might not be able to provide necessary care unless there 
is enhanced oncological productivity. Due to the increased 
need, stabilised health care costs, and the sustainable 
burden of hospitals, the involvement of primary care has 
been increasingly recognized as a vital component in the 
management of cancer survivors [9, 10].
To date, much of the studies mainly assessing the capa-
bility of primary care providers (PDPs) in survivorship care 
and indicate that the PDP’s skills and confidence may be 
lacking, but their skills could be enhanced by collaboration 
with hospital specialists [11, 12]. In addition, a landmark 
report from the US Institute of Medicine lists coordinative 
care between primary care and secondary care as an essen-
tial component for cancer survivorship care [13]. Shared 
care that integrate primary care and hospital care was 
originally created for patients with chronic disease [14], 
and it has been endorsed as an important component of 
high-quality of survivorship care [15]. Johnson et al. [16, p. 
350] defines shared care as:
“an organizational model involving both primary 
care physicians (PCPs) and specialists in a formal, 
explicit manner.”
Shared care does not only mean that both hospital and 
primary care join in the follow-up, but also means there 
is interaction between them. It is argues that the key 
points of this model are the communication between the 
care providers by exchange of information and arranging 
responsibility to improve the follow-up management [17].
The published reviews have focused on comparing 
the primary care provider and cancer specialist in the 
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management of cancer follow-up. Lewis et al. [5] released a 
systematic review that aimed to evaluate the effectiveness 
and cost-effectiveness of cancer follow-up by primary care. 
The author could not make a conclusion since the quality 
of data was generally poor and no statistically significant 
difference was found in the effectiveness of primary care 
follow-up. A second review [18] argued that local health 
care practitioners could benefit patients with physical and 
psychosocial problem in survivorship care, but proactive 
initiatives should be conducted to involve PDPs in the fol-
low-up. However, although integrating PCPs into the survi-
vorship care is needed, recent reviews found little evidence 
regarding the effectiveness of shared care, and there is a 
lack of standard models of shared care [6, 10, 14, 19].
Review questions and objectives
In this study, we systematically review the literature that 
focuses on the effectiveness and feasibility of shared care 
in the management of follow-up for cancer patients in 
different settings, and critically appraise the quality of 
evidence. The key objectives are: 1) to evaluate whether 
shared care is feasible or effective in the management of 
physical or psychological problems in cancer survivors; 
2) to provide a comprehensive review of the studies for 
achieving best practice in the management of follow-up 
for cancer survivors. The primary outcome will be whether 
shared care could solve the survivors’ physical or psycho-
logical problems, and patients’ attitudes toward shared 
care will be summarised. The physical problem could 
include the quality of life, the side effect, the recurrence 
rate, or any other symptoms. The psychological problems 
would include the anxiety, the distress level or other men-
tal health disorders. The secondary outcomes include the 
patient reported and practitioner reported satisfaction 
towards shared care, and the cost of shared care. Studies 
that assessed shared care in short- and long-term cancer 
survivors were both included and reported, but those 
assessed patients at the end of life were not included 
because they usually need more complicated care and a 
lot of them might stay in the intensive care unit or hos-
pice care unit [20].
Methods
Search strategy
The PRISMA systematic review and meta-analysis pro-
tocols (PRISMA-P) [21] was used as the guideline in this 
study, although minor changes were made to adapt to 
unanticipated circumstances. Six databases were searched 
based on the research question and objectives of this 
study—MEDLINE (Ovid), British Nursing Index, CINAHL 
(EBSCO), Cochrane Library, Health Management Informa-
tion Consortium (HMIC), and Social Care Online. Besides, 
two journals—Journal of Clinical Oncology and Journal 
of Adolescent and Young Adult Oncology were identified 
for hand searching, and all reference lists of the selected 
papers and relevant reviews were looked through. The 
search terms were identified based on the planned pop-
ulation, intervention, comparison, and outcome (PICO) 
[22], and they were adjusted slightly according to the dif-
ferent databases (see Appendix 1). Table 1 shows the core 
Table 1: Core components of the search strategy.
Population Intervention Context Outcome
cancer (MeSH) shared care (MeSH) follow-up (MeSH) All outcomes are included.
neoplasms (MeSH) co-management After care (MeSH)
cancer* “sharing of care” aftercare
neoplas* “collaborative care” follow up
malignan* “care coordination” followup*
carcinoma* “coordinated care” postsurgery
sarcoma “referral and consultation” post-surgery
oncolog* “cooperative behavio?r” postsurgical*
tumo?r* “shared service*” post-surgical*
adenocarcinoma* “delivery of health care” postoperat*
infiltrat* “integrated care” post-operat*
medullary “shared model” “continuity of patient care”
intraductal “inter-organizational coordination” “disease management”
surveillance
“disease progression”
survivorship
rehabilitation
post treatment
post-treatment
posttreatment
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components of the search strategy, and the last search was 
conducted on 17th May 2017.
Eligibility criteria
Inclusion criteria: 1) all types of primary research studies 
which assesses the shared care model in the management 
of follow-up for cancer patients, the formal interaction 
between primary care and secondary care; AND 2) include 
studies that examine any outcome in all types and any 
stage of cancer; AND 3) the population of interest included 
cancer survivors in any age; AND 4) published in English.
Exclusion criteria: 1) there was no formal interaction 
between primary care and secondary care as it is not 
shared care; OR 2) articles without outcomes such as com-
mentary, protocol, or meeting abstract; OR 3) the research 
did not report any outcome about shared care; OR 4) the 
healthcare service were provided by other practitioners 
rather than hospital specialists and primary care team, or 
a multidisciplinary team include other practitioners; OR 5) 
the patients did not finish all the curative intent or adju-
vant treatment; OR 6) the study only focus on the transi-
tion manner rather than the whole follow-up process.
Selection process and method of appraisal
The author screened the title and abstract first, and any 
study that seemed to meet the selection criteria was full-
text screened. Besides, two other reviewers randomly 
selected and reviewed 20% of the search records indepen-
dently. Subsequently, studies were picked out according to 
the inclusion criteria. Any discrepancies were discussed and 
where there was any uncertainty, the professor with experi-
ence in systematic reviews was consulted. In addition, the 
study author was contacted by email when more informa-
tion was needed. The reasons for excluding the studies were 
recorded to enable transparency of the selection process.
The Critical Appraisal Skills Programme (CASP) is a 
widely available appraisal tool developed by Oxford 
University, which includes eight checklists for the different 
types of studies [23]. The RCTs were appraised by the CASP 
Randomised Controlled Trial Checklist (see Appendix 2). 
The CASP comprises of 11 questions that assist a systematic 
thinking about the paper. The Health Care Practice R&D 
Unit (HCPRDU) has developed three checklists, with 6, 6, 7 
sections respectively, to appraise quantitative,  qualitative 
and mixed-method studies [24]. Thus, other studies were 
appraised with one of the HCPRDU checklists according to 
the research methodology (see Appendix 3, 4). Häggman-
Laitila et al. [25] evaluated the studies by selecting a score 
from 0 to 2 points in a systematic review, and this method 
was utilised and adapted for this review. For all studies, 
each question on the appraisal tools was scored from “0” 
to “2” separately and then the total scores were calculated. 
Among them, “0” means many limitations, “1” means 
some limitation, and “2” means excellent.
Data collection and synthesis of the findings
Gough et al. [26] argue that the content of both quantita-
tive and qualitative studies should be described and coded 
first, then the data extracted from these descriptions 
can be synthesised into the findings. Therefore, the the-
matic analysis, which is a widespread analytical method 
to accommodate a diversity of studies including both 
experimental and observational studies [27], was used in 
this review. Besides, since the data in the selected stud-
ies are not sufficiently similar to allow for meta-analysis, 
the narrative approach was utilised in this review [28]. 
First, one author extracted the information and the other 
author verified all the information, the disagreements 
were solved by discussion; second, after a comprehensive 
understanding of all the results and a critical scrutiny of 
the themes was achieved, the final theme was summa-
rised from all the papers in order to answer the research 
question; finally, the sample size, the study design, the 
limitation, and the quality of evidence were considered 
when there were conflicting themes, and the study with 
larger sample size or better quality might contribute more 
to the conclusion. The main review focus on the objectives 
of the systematic review, and the subgroup analysis were 
also included when they important to answer the ques-
tions of the review questions.
Results
A total of 1,888 records were identified through six data-
bases, with 521 records identified through hand searching 
two oncology journals and citation tracking. All records 
were imported into Endnote, and 1,698 records were 
adopted after removing the duplicates by Endnote and 
scanning the title and authors. Then, the remaining 1,698 
records were reviewed according to the eligibility criteria 
by two steps. First, the title and abstract of the records 
were reviewed in Endnote. Next, the potential studies 
were downloaded, and the full-text reviewed. Finally, 
twelve studies met the inclusion criteria, eight of which 
were RCTs, three of which were observational quantitative 
studies, and one was a mixed-method study. The selection 
process is illustrated in Figure 1. The study description 
based on the PICO framework is illustrated in Tables 2 
and 3. Besides, the essence of shared care that includes 
the methods of communication, the major care provider, 
and the length of follow-up is described in Table 4.
Data extraction and quality appraisal
All studies except the mixed-method study [29] were con-
sidered as excellent or good quality, and were included. 
To keep a balance between having confidence about the 
findings by only including good quality evidence and com-
prising enough evidence in order to answer the research 
question, only those studies which were considered as bad 
quality were excluded [30]. As a result, this review finally 
includes seven RCTs reported in eight papers and three 
descriptive quantitative studies. One RCT was reported in 
two papers which assessed different types of outcomes [31, 
32]. The results of the quality appraisal of the studies can be 
found in Tables 5 and 6 (included studies), and Appendix 7 
(excluded study), and the examples of the appraisal process 
with the checklist can be found in Appendix 5, 6, and 7.
Effectiveness of shared care
Physical and psychological health status
A total of seven papers assessed whether shared care 
could improve the survivors’ health status, including 
both physical and psychological improvements. Among 
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those six papers that detected the quality of life, five 
papers detected the differences between the two arms 
at the end of the intervention, and one paper compared 
the outcomes between the beginning and the end of the 
shared care, but none of these papers detected any sig-
nificant difference [31, 33–37]. As for the survivors’ psy-
chological status, the two papers evaluated the survivors’ 
psychological distress level, finding no significant differ-
ence between the intervention group and control group 
[31, 37]. Besides, the paper that assessed the survivorship 
worries found no difference before and after the shared 
care, but there was a borderline difference between the 
two groups after the shared care [38]. Turning to the sur-
vivors’ physical conditions, the paper that evaluated the 
survivors’ performance status found no significant differ-
ences between the two arms [33]. Further, the study used 
a non-inferiority design to evaluate the number of recur-
rences, death, and the serious clinical event could not 
demonstrate whether the intervention group was worse 
than the control group [35].
Satisfaction, attitudes and needs towards health care
Seven out of eleven papers evaluated the survivors’ attitudes 
and needs toward the shared care. The results include the 
satisfaction with the follow-up [34, 37, 38], the satisfaction 
towards the PCPs [36], the attitudes toward the cooperation 
between health providers [33], the attitudes toward the 
information they received [39], survivorship unmet needs 
[37], and the preference for the care provider [37, 38]. From 
the survivor report results, the cooperation between health 
care practitioners improved (p = 0.025 and p = 0.004 in two 
out of four items) in the intermediate outcomes [33], and 
Emery et al. found the survivors in the shared care group 
would prefer shared care in the follow-up after the study 
(p = 0.07) [37]. Apart from these, the studies found no other 
significant differences between the two arms.
Figure 1: PRISMA flow diagram.
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G
P 
fo
llo
w
-u
p,
 b
ut
 th
e 
im
pr
ov
em
en
ts
 w
er
e 
no
t 
id
en
ti
fie
d 
th
is
 s
tu
dy
. 
Be
si
de
s,
 th
e 
in
te
rv
en
-
ti
on
 d
id
 n
ot
 g
en
er
at
e 
cl
os
er
 c
on
ta
ct
 b
et
w
ee
n 
pa
ti
en
ts
 a
nd
 th
ei
r 
G
Ps
.
(c
on
td
.)
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A
ut
ho
r,
 y
ea
r,
 
 co
un
tr
y
Sa
m
pl
e 
an
d 
se
tt
in
g 
In
te
rv
en
ti
on
 g
ro
up
Co
nt
ro
l 
gr
ou
p
Le
ng
th
 o
f f
ol
lo
w
-
up
,  i
nc
lu
si
on
 t
im
e
Ca
nc
er
 t
yp
e
O
ut
co
m
es
Co
nc
lu
si
on
G
ru
nf
el
d,
 
et
 a
l. 
[3
5]
, 
20
06
, C
an
ad
a
96
8 
ea
rl
y-
st
ag
e 
br
ea
st
 
ca
nc
er
 p
at
ie
nt
s 
fr
om
 
si
x 
ca
nc
er
 c
en
tr
es
 
w
er
e 
en
ro
lle
d 
fr
om
 
Ja
nu
ar
y 
19
97
 to
 Ju
ne
 
20
01
.
n 
= 
48
3,
 th
e 
fa
m
ily
 p
hy
si
ci
an
 
re
ce
iv
ed
 a
 o
ne
-p
ag
e 
gu
id
el
in
e 
fr
om
 th
e 
ca
nc
er
 c
en
tr
e.
 T
he
 
gu
id
el
in
e 
in
cl
ud
ed
 fo
llo
w
-u
p 
ar
ra
ng
em
en
t, 
re
fe
rr
al
 in
st
ru
c-
ti
on
, a
nd
 d
is
ea
se
 re
le
va
nt
 
 in
fo
rm
at
io
n.
 T
he
 p
at
ie
nt
s 
re
ce
iv
ed
 fo
llo
w
-u
p 
ca
re
 fr
om
 
th
ei
r f
am
ily
 p
hy
si
ci
an
.
n 
= 
48
5,
 
th
e 
pa
ti
en
ts
 
re
ce
iv
ed
 
fo
llo
w
-u
p 
ca
re
 fr
om
 
ca
nc
er
 
ce
nt
re
Fr
om
 le
ss
 th
an
 2
 
ye
ar
s 
to
 5
 y
ea
rs
, 
pa
ti
en
ts
 w
ho
 h
ad
 
be
en
 d
ia
gn
os
ed
 
w
it
h 
ca
nc
er
 fr
om
 9
 
to
 1
5 
m
on
th
s 
ag
o 
an
d 
ha
d 
co
m
-
pl
et
ed
 tr
ea
tm
en
t 3
 
m
on
th
s 
ag
o
ea
rl
y 
st
ag
e 
br
ea
st
 c
an
ce
r
Th
e 
pe
rc
en
ta
ge
 o
f r
ec
ur
re
nc
e,
 
de
at
h,
 a
nd
 s
er
io
us
 c
lin
ic
al
 e
ve
nt
 
in
 s
ha
re
d 
ca
re
 g
ro
up
 w
er
e 
11
.2
%
, 
6.
0%
, a
nd
 3
.5
%
, r
es
pe
ct
iv
el
y,
 
co
m
pa
re
d 
to
 1
3.
2%
, 6
.2
%
, a
nd
 
3.
7%
, r
es
pe
ct
iv
el
y,
 in
 c
on
tr
ol
 g
ro
up
. 
Th
e 
he
al
th
-r
el
at
ed
 q
ua
lit
y 
of
 li
fe
 
th
at
 a
ss
es
se
d 
by
 S
F-
36
 a
nd
 H
A
D
S 
be
tw
ee
n 
tw
o 
ar
m
s 
di
d 
no
t s
ho
w
 
si
gn
ifi
ca
nt
 d
iff
er
en
ce
s.
Th
e 
sh
ar
ed
 c
ar
e 
fo
llo
w
-
up
 d
id
 n
ot
 in
cr
ea
se
 
th
e 
ri
sk
 o
f i
m
po
rt
an
t 
re
cu
rr
en
ce
-r
el
at
ed
 
se
ri
ou
s 
cl
in
ic
al
 e
ve
nt
 o
r 
he
al
th
-r
el
at
ed
 q
ua
lit
y 
of
 li
fe
 fo
r 
br
ea
st
 c
an
ce
r 
pa
ti
en
ts
.
 Bl
aa
uw
br
oe
k,
 
et
 a
l. 
[3
6]
, 
20
08
, 
 N
et
he
rl
an
ds
( h
is
to
ri
ca
l 
co
nt
ro
l 
de
si
gn
)
12
1 
ad
ul
t s
ur
vi
vo
rs
 
(≧
18
 y
ea
rs
) w
ho
 u
se
d 
to
 b
e 
di
ag
no
se
d 
as
 
ch
ild
ho
od
 c
an
ce
r i
n 
a 
pa
ed
ia
tr
ic
 o
nc
ol
og
y 
de
pa
rt
m
en
t a
nd
 d
id
 
no
t j
oi
n 
an
y 
fo
llo
w
-u
p 
st
ud
y 
ag
re
ed
 to
 e
nt
er
 
th
e 
st
ud
y 
in
 2
00
4 
an
d 
20
05
.
n 
= 
12
1,
 th
re
e 
vi
si
ts
 w
er
e 
ca
r-
ri
ed
 o
ut
 d
ur
in
g 
th
re
e 
ye
ar
s 
pe
ri
od
. V
is
it
 1
 a
nd
 v
is
it
 3
 w
er
e 
co
nd
uc
te
d 
by
 a
n 
on
-s
it
e 
fa
m
ily
 
 do
ct
or
 a
t t
he
 m
ed
ic
al
 c
en
tr
e,
 
vi
si
t 2
 w
as
 c
on
du
ct
ed
 b
y 
th
e 
lo
ca
l f
am
ily
 d
oc
to
r. 
A
ss
es
s-
m
en
ts
, s
ur
ve
y,
 a
nd
 in
di
vi
du
al
-
is
ed
 fo
llo
w
-u
p 
su
gg
es
ti
on
 w
er
e 
pr
ov
id
ed
 in
 th
es
e 
vi
si
ts
.
Th
e 
da
ta
 
fr
om
 
an
ot
he
r 
m
at
ch
ed
 
st
ud
y 
in
 th
e 
N
et
he
rl
an
ds
 
w
as
 u
se
d 
as
 c
on
tr
ol
 
gr
ou
p 
da
ta
.
ye
ar
s,
 a
ll 
pa
ti
en
ts
 
ha
d 
be
en
 tr
ea
te
d 
in
 
th
e 
ho
sp
it
al
 a
t l
ea
st
 
5 
ye
ar
s 
ag
o
A
ll 
ch
ild
ho
od
 
ca
nc
er
s 
an
d 
La
ng
er
ha
ns
-
ce
ll 
hi
st
io
cy
-
to
si
s,
 e
xc
ep
t 
ce
nt
ra
l n
er
v-
ou
s 
sy
st
em
 
tu
m
ou
rs
A
t v
is
it
 1
, p
at
ie
nt
s 
in
 in
te
rv
en
ti
on
 
ar
m
 s
ho
w
ed
 lo
w
er
 le
ve
l o
f h
ea
lt
h-
re
la
te
d 
qu
al
it
y 
of
 li
fe
 w
it
h 
RA
N
D
-3
6 
su
rv
ey
 c
om
pa
re
d 
to
 c
on
tr
ol
 g
ro
up
 
da
ta
, b
ut
 n
o 
si
gn
ifi
ca
nt
 d
iff
er
en
ce
s 
w
er
e 
de
te
ct
ed
 a
t v
is
it
 3
. P
at
ie
nt
 s
at
-
is
fa
ct
io
n 
w
as
 a
ss
es
se
d 
at
 v
is
it
 2
, a
nd
 
89
 (8
8%
) o
f t
he
 1
01
 p
at
ie
nt
s 
w
er
e 
sa
ti
sf
ie
d 
w
it
h 
sh
ar
ed
 c
ar
e 
m
od
el
.
Sh
ar
ed
 c
ar
e 
in
vo
lv
ed
 
pa
ed
ia
tr
ic
 o
nc
ol
og
is
ts
 
an
d 
fa
m
ily
 d
oc
to
rs
 c
an
 
be
 u
se
d 
in
 th
e 
lo
ng
-t
er
m
 
fo
llo
w
-u
p 
in
 c
hi
ld
ho
od
 
ca
nc
er
 p
at
ie
nt
s.
Em
er
y,
 e
t a
l. 
[3
7]
, 2
01
7,
 
A
us
tr
al
ia
pr
os
ta
te
 c
an
ce
r 
pa
ti
en
ts
 w
it
h 
lo
w
 
ri
sk
 o
r m
od
er
at
e 
ri
sk
 fe
at
ur
es
 w
er
e 
re
cr
ui
te
d 
fr
om
 tw
o 
ru
ra
l a
nd
 fo
ur
 u
rb
an
 
m
ed
ic
al
 c
en
tr
es
 fr
om
 
 N
ov
em
be
r 2
01
1 
to
 
Ju
ly
 2
01
3.
n 
= 
45
, a
 G
P 
vi
si
t w
as
 c
on
du
ct
ed
 
to
 re
-e
ng
ag
e 
th
ei
r r
el
at
io
n-
sh
ip
 w
it
h 
pa
ti
en
ts
. B
es
id
es
, t
he
 
tr
ea
tm
en
t c
en
tr
e 
pr
ov
id
ed
 a
 S
CP
 
to
 th
e 
pa
ti
en
ts
 a
nd
 th
ei
r G
Ps
, 
an
d 
a 
re
gi
st
er
 a
nd
 re
ca
ll 
sy
st
em
 
w
as
 b
ui
lt
 to
 e
nh
an
ce
 G
Ps
’ a
nd
 
pa
ti
en
ts
’ c
om
pl
ia
nc
e.
 A
ft
er
 th
at
, 
G
P 
re
pl
ac
ed
 tw
o 
ho
sp
it
al
 ro
ut
in
e 
fo
llo
w
-u
p 
vi
si
ts
 a
t 6
 m
on
th
s 
an
d 
9 
m
on
th
s.
 
n 
= 
43
, 
us
ua
l 
ca
re
 (t
he
 
pa
ti
en
ts
 
vi
si
te
d 
th
e 
ho
sp
it
al
 
sp
ec
ia
lis
ts
 
ev
er
y 
th
re
e 
m
on
th
s)
m
on
th
s,
 a
ll 
pa
ti
en
ts
 
ha
d 
co
m
pl
et
ed
 
cu
ra
ti
ve
 in
te
nt
 
tr
ea
tm
en
ts
 w
it
hi
n 
th
e 
pr
ev
io
us
 8
 
w
ee
ks
Pr
os
ta
te
 
ca
nc
er
 w
it
h 
lo
w
 ri
sk
 o
r 
m
od
er
at
e 
ri
sk
 fe
at
ur
es
, 
ex
pe
ct
 th
e 
m
et
as
ta
ti
c 
di
se
as
e
N
o 
si
gn
ifi
ca
nt
 d
iff
er
en
ce
s 
be
tw
ee
n 
tw
o 
gr
ou
ps
 w
it
h 
th
e 
H
A
D
S,
 th
e 
Ca
SU
N
, t
he
 E
PI
C,
 a
nd
 th
e 
PS
Q
-1
8 
re
su
lt
s.
 B
ut
 th
e 
in
te
rv
en
ti
on
 g
ro
up
 
ha
d 
a 
pr
ef
er
en
ce
 o
f s
ha
re
d 
ca
re
 
th
an
 c
on
tr
ol
 g
ro
up
 (P
 <
 0
.0
01
), 
an
d 
sh
ar
ed
 c
ar
e 
co
st
s 
le
ss
 th
an
 u
su
al
 
ca
re
.
Sh
ar
ed
 c
ar
e 
m
od
el
 c
ou
ld
 
no
t b
en
ef
it
 p
ro
st
at
e 
ca
nc
er
 p
at
ie
nt
s 
w
it
h 
di
st
re
ss
, u
nm
et
 n
ee
ds
, 
ca
nc
er
-s
pe
ci
fic
 q
ua
lit
y 
of
 
lif
e,
 o
r 
sa
ti
sf
ac
ti
on
, b
ut
 it
 
is
 fe
as
ib
le
 a
s 
to
 p
ro
vi
de
 
a 
si
m
ila
r 
ou
tc
om
e 
w
it
h 
le
ss
 m
on
ey
. 
(c
on
td
.)
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A
ut
ho
r,
 y
ea
r,
 
 co
un
tr
y
Sa
m
pl
e 
an
d 
se
tt
in
g 
In
te
rv
en
ti
on
 g
ro
up
Co
nt
ro
l 
gr
ou
p
Le
ng
th
 o
f f
ol
lo
w
-
up
,  i
nc
lu
si
on
 t
im
e
Ca
nc
er
 t
yp
e
O
ut
co
m
es
Co
nc
lu
si
on
M
ay
er
, e
t a
l.,
 
[3
8]
, 2
01
6,
 
U
ni
te
d 
St
at
es
 
37
 c
an
ce
r p
at
ie
nt
s 
(≧
21
 y
ea
rs
) w
ho
 h
ad
 
co
m
pl
et
ed
 c
ur
at
iv
e 
in
te
nt
 tr
ea
tm
en
t i
n 
a 
ca
nc
er
 h
os
pi
ta
l w
er
e 
re
cr
ui
te
d.
n 
= 
20
, t
he
 re
se
ar
ch
 n
ur
se
 in
 th
e 
ho
sp
it
al
 m
ad
e 
a 
dr
af
t S
CP
, t
he
n 
th
e 
on
co
lo
gy
 n
ur
se
 p
ra
ct
it
io
ne
r 
m
ad
e 
a 
40
 m
in
ut
es
 tr
an
si
ti
on
 
vi
si
t w
it
h 
th
e 
pa
ti
en
t a
nd
 re
vi
se
d 
th
e 
SC
P.
 T
he
 fi
na
l S
CP
 w
as
 s
en
t 
to
 b
ot
h 
pa
ti
en
ts
 a
nd
 th
ei
r P
CP
s.
 
Be
si
de
s,
 th
e 
PC
Ps
 re
ce
iv
ed
 re
le
-
va
nt
 k
no
w
le
dg
e 
ab
ou
t f
ol
lo
w
-u
p.
 
A
ft
er
w
ar
ds
, t
he
 P
CP
s 
ca
rr
ie
d 
ou
t 
a 
se
m
i-s
tr
uc
tu
re
d 
fo
llo
w
-u
p 
vi
si
t 
w
it
h 
pa
ti
en
ts
 w
it
hi
n 
fo
ur
 w
ee
ks
.
n 
= 
17
, t
he
 
sa
m
e 
w
it
h 
in
te
rv
en
ti
on
 
gr
ou
p 
bu
t 
w
it
ho
ut
 G
P 
vi
si
t 
6 
w
ee
ks
, a
ll 
pa
ti
en
ts
 
ha
d 
co
m
pl
et
ed
 
cu
ra
ti
ve
 in
te
nt
 
tr
ea
tm
en
ts
 w
it
hi
n 
th
e 
pr
ev
io
us
 4
 to
 6
 
w
ee
ks
A
ll 
ty
pe
s 
of
 
ca
nc
er
 e
xc
ep
t 
m
et
as
ta
ti
c 
ca
nc
er
A
ll 
pa
ti
en
ts
 r
ep
or
te
d 
ha
vi
ng
 le
ss
 
co
nt
ra
di
ct
or
y 
in
fo
rm
at
io
n 
ab
ou
t 
ca
re
 (P
 <
 0
.0
00
1)
 a
nd
 e
xp
ec
te
d 
le
ss
 fo
llo
w
-u
p 
fr
om
 o
nc
ol
og
is
ts
 
(P
 =
 0
.0
3)
 a
t 6
 w
ee
ks
. A
ll 
PC
Ps
 fe
lt
 
m
or
e 
co
nf
id
en
t (
P 
= 
0.
01
) a
bo
ut
 
su
rv
iv
or
sh
ip
 c
ar
e.
 H
ow
ev
er
, t
he
 P
CP
 
vi
si
t h
as
 li
tt
le
 e
ff
ec
t o
n 
th
e 
re
su
lt
s,
 
ex
ce
pt
 m
ak
in
g 
a 
bo
rd
er
lin
e 
di
ff
er
-
en
ce
 w
it
h 
w
or
ry
 le
ve
l (
P 
= 
0.
05
). 
Th
e 
SC
P 
co
ul
d 
im
pr
ov
e 
pa
ti
en
ts
’ a
nd
 P
CP
’s
 
co
nf
id
en
ce
 in
 s
ur
vi
vo
r-
sh
ip
 in
fo
rm
at
io
n,
 b
ut
 
no
 s
ig
ni
fic
an
t b
en
ef
it
 
w
as
 id
en
ti
fie
d 
ab
ou
t G
P 
vi
si
t. 
Th
is
 is
 a
 p
ilo
t s
tu
dy
, 
a 
la
rg
er
 s
tu
dy
 s
ho
ul
d 
ex
pl
or
e 
th
e 
ch
an
ge
s 
in
 
th
e 
fu
tu
re
.
G
P 
= 
ge
ne
ra
l p
ra
ct
it
io
ne
r. 
EO
RT
C 
Q
LQ
-C
30
 =
 th
e 
Eu
ro
pe
an
 O
rg
an
is
at
io
n 
fo
r 
Re
se
ar
ch
 a
nd
 T
re
at
m
en
t o
f C
an
ce
r 
Q
ua
lit
y 
of
 L
ife
 Q
ue
st
io
nn
ai
re
 C
or
e 
30
. P
O
M
S 
= 
Pr
of
ile
 o
f M
oo
d 
St
at
es
 S
ca
le
. R
A
N
D
-3
6 
= 
RA
N
D
 3
6-
It
em
 H
ea
lt
h 
Su
rv
ey
. S
CP
: s
ur
vi
vo
rs
hi
p 
ca
re
 p
la
n.
 H
A
D
S 
= 
14
-it
em
 H
os
pi
ta
l A
nx
ie
ty
 a
nd
 D
ep
re
ss
io
n 
Sc
al
e.
 C
aS
U
N
 =
 U
nm
et
 n
ee
ds
 w
er
e 
as
se
ss
ed
 w
it
h 
th
e 
Ca
nc
er
 S
ur
vi
vo
rs
’ U
nm
et
 N
ee
ds
 
m
ea
su
re
. E
PI
C 
= 
Ex
pa
nd
ed
 P
ro
st
at
e 
Ca
nc
er
 In
de
x 
Co
m
po
si
te
. P
SQ
-1
8 
= 
18
-it
em
 S
ho
rt
-fo
rm
 P
at
ie
nt
 S
at
is
fa
ct
io
n 
Q
ue
st
io
nn
ai
re
. S
F-
36
 =
 M
ed
ic
al
 O
ut
co
m
es
 S
tu
dy
 S
ho
rt
 F
or
m
 3
6-
It
em
 G
en
er
al
 H
ea
lt
h 
Su
rv
ey
.
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Ta
bl
e 
3
: O
ve
rv
ie
w
 o
f t
he
 o
th
er
 s
tu
di
es
.
A
ut
ho
r,
 y
ea
r,
 
co
un
tr
y
Re
se
ar
ch
 
de
si
gn
Sa
m
pl
e 
an
d 
se
tt
in
g
Pr
oc
ed
ur
es
 (I
nt
er
ve
nt
io
n 
an
d 
co
m
pa
ri
so
n)
Le
ng
th
 o
f f
ol
lo
w
-
up
, o
ns
et
 t
im
e
Ca
nc
er
 t
yp
e
O
ut
co
m
es
Co
nc
lu
si
on
H
an
an
, e
t a
l.,
 [2
9]
, 
20
14
, I
re
la
nd
 
 D
es
cr
ip
ti
ve
, 
 si
ng
le
-c
en
tr
e,
 
m
ix
ed
 
 m
et
ho
ds
Th
e 
co
m
m
un
it
y 
nu
rs
e 
to
ok
 th
e 
 re
sp
on
si
bi
lit
y 
of
 m
an
ag
em
en
t o
f 
ca
nc
er
 p
at
ie
nt
s 
in
st
ea
d 
of
 h
os
pi
ta
l n
ur
se
s,
 
an
d 
th
e 
vi
si
t w
as
 
co
nd
uc
te
d 
at
 p
at
ie
nt
s’
 
ho
m
e.
Th
e 
re
se
ar
ch
 in
cl
ud
ed
 a
 
si
x 
m
on
th
s 
sk
ill
s 
tr
ai
ni
ng
 
(f
ro
m
 s
pe
ci
al
is
t c
an
ce
r 
st
af
f)
 fo
r c
om
m
un
it
y 
nu
rs
es
, s
pe
ci
fic
 re
fe
rr
al
 
fo
rm
, a
nd
 p
ro
vi
de
d 
ho
sp
i-
ta
l s
up
po
rt
 fo
r c
om
m
un
it
y 
nu
rs
es
 in
 u
rg
en
t s
it
ua
ti
on
 
by
 p
ho
ne
. T
he
 p
at
ie
nt
s 
w
er
e 
to
ld
 th
at
 th
e 
m
ed
ic
al
 
on
co
lo
gi
st
s 
st
ill
 to
ok
 th
e 
re
sp
on
si
bi
lit
y 
of
 th
em
. 
Th
e 
pa
ti
en
ts
 w
er
e 
m
aj
or
ly
 
m
an
ag
ed
 b
y 
co
m
m
un
it
y 
nu
rs
es
.
5 
ye
ar
s,
 n
ot
 
 m
en
ti
on
ed
N
ot
 m
en
ti
on
ed
 
Q
ua
nt
it
at
iv
e 
ou
tc
om
es
:  
Co
m
m
un
it
y 
nu
rs
e-
le
d 
ca
nc
er
 c
ar
e 
w
as
 
co
m
pa
re
d 
w
it
h 
ho
sp
it
al
 a
ct
iv
it
y 
da
ta
 
be
fo
re
 th
e 
pr
og
ra
m
m
e 
(b
as
el
in
e)
, i
n 
th
e 
m
id
dl
e 
of
 th
e 
pr
og
ra
m
m
e 
(a
ft
er
 
th
e 
si
x 
m
on
th
s 
tr
ai
ni
ng
), 
an
d 
fiv
e 
ye
ar
s 
af
te
r 
th
e 
ba
se
lin
e.
 T
he
 c
om
m
un
it
y 
nu
rs
es
 d
el
iv
er
ed
 s
af
e 
ca
nc
er
 c
ar
e,
 a
nd
 
th
e 
ho
sp
it
al
 a
tt
en
da
nc
es
 w
as
 d
ec
re
as
ed
. 
Th
e 
co
m
m
un
it
y 
nu
rs
es
 h
ad
 m
or
e 
 co
nf
id
en
ce
 in
 c
an
ce
r 
m
an
ag
em
en
t.
Q
ua
lit
at
iv
e 
ou
tc
om
es
:  
Th
e 
pa
ti
en
ts
 r
ep
or
te
d 
a 
sh
or
te
r 
tr
av
el
 
to
 h
ea
lt
h 
ca
re
, a
nd
 im
pr
ov
ed
 q
ua
lit
y 
of
 
lif
e.
 T
he
y 
ha
d 
co
nf
id
en
ce
 in
 c
om
m
un
it
y 
nu
rs
es
, a
nd
 th
ey
 in
di
ca
te
d 
th
ei
r 
se
ns
e 
of
 a
ut
on
om
y 
in
cr
ea
se
d.
Sh
ar
ed
 c
ar
e 
ap
pr
oa
ch
 w
it
h 
tr
ai
ni
ng
 c
om
m
un
it
y 
nu
rs
es
 c
ou
ld
  b
en
ef
it
 
bo
th
 p
at
ie
nt
s 
an
d 
he
al
th
 c
ar
e 
 pr
ov
id
er
s.
Bl
aa
uw
br
oe
k,
et
 a
l. 
[3
9]
, 2
01
2,
 
 N
et
he
rl
an
ds
 
D
es
cr
ip
ti
ve
, 
si
ng
le
-c
en
tr
e,
 
qu
an
ti
ta
ti
ve
80
 c
hi
ld
ho
od
 c
an
ce
r 
su
rv
iv
or
s 
(≧
18
 y
ea
rs
) 
w
ho
 u
se
d 
to
 b
e 
di
ag
-
no
se
d 
in
 a
 lo
ng
-t
er
m
 
fo
llo
w
-u
p 
cl
in
ic
 a
nd
 
di
d 
no
t j
oi
n 
an
y 
fo
llo
w
-
up
 s
tu
dy
 a
nd
 th
ei
r 
fa
m
ily
 d
oc
to
rs
 (n
 =
 7
9)
 
jo
in
ed
 th
is
 s
tu
dy
 fr
om
 
 Se
pt
em
be
r 2
00
8.
Th
e 
re
se
ar
ch
 te
am
 
( h
os
pi
ta
l s
pe
ci
al
is
ts
) 
 co
ns
tr
uc
te
d 
a 
pe
rs
on
al
is
ed
 
SC
P 
an
d 
se
nt
 th
e 
pr
in
te
d 
bo
ok
le
t t
o 
th
e 
pa
ti
en
ts
. 
Th
e 
pl
an
 w
as
 a
ls
o 
ac
ce
s-
si
bl
e 
th
ro
ug
h 
a 
se
cu
re
 
w
eb
si
te
 to
 th
e 
su
rv
iv
or
s 
an
d 
th
ei
r f
am
ily
  d
oc
to
rs
. 
Be
si
de
s,
 th
e 
re
se
ar
ch
 te
am
 
as
ke
d 
th
e 
su
rv
iv
or
s 
to
 
m
ak
e 
a 
ha
lf-
ho
ur
 m
ee
ti
ng
 
w
it
h 
th
ei
r f
am
ily
 d
oc
to
rs
, 
th
ey
 w
ou
ld
 re
m
in
d 
th
e 
su
r-
vi
vo
rs
 a
ga
in
 if
 th
ey
 d
id
 n
ot
 
m
ee
t t
he
ir
 fa
m
ily
 d
oc
to
rs
 
si
x 
m
on
th
s 
la
te
r. 
Fo
llo
w
-u
p 
w
as
 d
on
e 
pr
im
ar
ily
 b
y 
th
e 
fa
m
ily
 d
oc
to
r.
on
e 
ye
ar
, a
t 
le
as
t 5
 y
ea
rs
 
 of
f-t
re
at
m
en
t
A
ll 
ty
pe
s 
of
 
ca
nc
er
 e
xp
ec
t 
ce
nt
ra
l n
er
vo
us
 
sy
st
em
 tu
m
ou
rs
, 
su
rv
iv
or
s 
of
 a
ll 
th
re
e 
le
ve
ls
 o
f r
is
k 
w
er
e 
in
cl
ud
ed
 
( lo
w
-r
is
k,
 
m
ed
iu
m
-r
is
k,
 
an
d 
hi
gh
 ri
sk
)
Th
e 
fa
m
ily
 d
oc
to
rs
 w
er
e 
as
ke
d 
to
 fi
ni
sh
 
an
 in
fo
rm
at
io
n 
fo
rm
 a
bo
ut
 th
e 
sc
re
en
-
in
g 
an
d 
th
e 
ad
di
ti
on
al
 te
st
 r
es
ul
ts
. 
Be
si
de
s,
 a
n 
18
-it
em
 q
ue
st
io
nn
ai
re
 a
nd
 
a 
14
-it
em
 q
ue
st
io
nn
ai
re
 w
er
e 
us
ed
 to
 
as
se
ss
 s
ur
vi
vo
rs
’ a
nd
 fa
m
ily
 d
oc
to
rs
’ 
vi
ew
s,
 r
es
pe
ct
iv
el
y,
 a
bo
ut
 th
e 
w
eb
si
te
 
an
d 
th
e 
pr
ov
id
ed
 in
fo
rm
at
io
n,
 th
e 
la
te
 
ef
fe
ct
s 
w
er
e 
al
so
 c
ol
le
ct
ed
 b
y 
th
e 
fa
m
ily
 
do
ct
or
s.
O
ut
co
m
es
: 
73
 s
ur
vi
vo
rs
 a
nd
 7
2 
fa
m
ily
 d
oc
to
rs
 
co
m
pl
et
ed
 th
e 
st
ud
y.
 9
7%
 o
f t
he
 
su
rv
iv
or
s 
th
ou
gh
t t
he
 fo
llo
w
-u
p 
w
as
 
be
ne
fic
ia
l, 
bu
t 1
1%
 o
f t
he
 s
ur
vi
vo
rs
 fe
lt
 
th
at
 th
e 
in
fo
rm
at
io
n 
w
as
 in
ad
eq
ua
te
. 
82
%
 o
f t
he
 s
ur
vi
vo
rs
 b
el
ie
ve
d 
in
 th
ei
r 
fa
m
ily
 d
oc
to
rs
’ a
bi
lit
y 
in
 th
e 
fo
llo
w
-u
p.
 
H
ow
ev
er
, 7
7%
 o
f s
ur
vi
vo
rs
 fe
lt
 w
or
ri
ed
 
ab
ou
t t
he
 r
ea
w
ak
en
ed
 m
em
or
ie
s 
ab
ou
t 
th
e 
di
se
as
e.
Th
e 
sh
ar
ed
 c
ar
e 
w
it
h 
w
eb
-b
as
ed
 S
CP
 is
 
av
ai
la
bl
e 
in
 th
e 
lo
ng
-
te
rm
 c
an
ce
r 
fo
llo
w
-
up
 o
f a
du
lt
s 
w
it
h 
ch
ild
ho
od
 c
an
ce
r, 
an
d 
m
os
t s
ur
vi
vo
rs
 
an
d 
fa
m
ily
 d
oc
to
rs
 
w
er
e 
sa
ti
sf
ie
d 
w
it
h 
th
is
 m
od
el
. B
es
id
es
, 
bo
th
 s
ur
vi
vo
rs
 a
nd
 
th
e 
fa
m
ily
  d
oc
to
rs
 
th
ou
gh
t t
he
ir
 
re
le
va
nt
 k
no
w
le
dg
e 
im
pr
ov
ed
 th
ou
gh
 
th
is
 p
ro
ce
ss
. T
he
 
ne
ga
ti
ve
 e
ff
ec
t w
as
 
th
e 
fo
llo
w
-u
p 
m
ig
ht
 
re
aw
ak
en
 s
ur
vi
vo
rs
 
of
 b
ad
 m
em
or
ie
s 
ab
ou
t d
is
ea
se
.
(c
on
td
.)
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A
ut
ho
r,
 y
ea
r,
 
co
un
tr
y
Re
se
ar
ch
 
de
si
gn
Sa
m
pl
e 
an
d 
se
tt
in
g
Pr
oc
ed
ur
es
 (I
nt
er
ve
nt
io
n 
an
d 
co
m
pa
ri
so
n)
Le
ng
th
 o
f f
ol
lo
w
-
up
, o
ns
et
 t
im
e
Ca
nc
er
 t
yp
e
O
ut
co
m
es
Co
nc
lu
si
on
60
 fa
m
ily
 d
oc
to
rs
 (8
3%
) f
in
is
he
d 
al
l t
he
 
re
co
m
m
en
de
d 
te
st
s.
 9
5%
 o
f t
he
 fa
m
ily
 
do
ct
or
s 
fe
lt
 th
e 
fo
llo
w
-u
p 
w
as
 m
or
e 
be
ne
fic
ia
l a
nd
 8
3%
 fe
lt
 th
ei
r 
kn
ow
l-
ed
ge
 o
f l
at
e 
ef
fe
ct
s 
in
cr
ea
se
d.
 B
es
id
es
, 
93
%
 o
f t
he
 fa
m
ily
 d
oc
to
rs
 fe
lt
 c
on
fi-
de
nt
 a
bo
ut
 m
an
ag
em
en
t o
f f
ol
lo
w
-u
p 
if 
th
ey
 r
ec
ei
ve
d 
th
e 
SC
P.
Be
rg
er
, e
t a
l.,
 [4
0]
, 
20
17
, F
ra
nc
e 
D
es
cr
ip
ti
ve
, 
si
ng
le
-c
en
tr
e,
 
qu
an
ti
ta
ti
ve
15
0 
ch
ild
ho
od
 c
an
ce
r 
su
rv
iv
or
s 
(≧
18
 y
ea
rs
) 
an
d 
th
ei
r G
Ps
 (n
 =
 1
06
) 
in
vo
lv
ed
 in
 th
is
 s
tu
dy
 
fr
om
 D
ec
em
be
r 2
01
0 
to
 Ju
ne
 2
01
3.
 T
he
se
 
su
rv
iv
or
s 
w
er
e 
fr
om
 a
 
re
gi
on
 c
an
ce
r r
eg
is
tr
y 
an
d 
di
ag
no
se
d 
of
 
 ca
nc
er
 b
ef
or
e 
15
 y
ea
rs
 
ol
d.
Th
e 
pa
ed
ia
tr
ic
 o
nc
ol
og
is
t 
an
d 
th
e 
in
te
rn
is
t i
nv
it
ed
 
th
e 
su
rv
iv
or
s 
to
 jo
in
 a
 
co
ns
ul
ta
ti
on
, i
n 
w
hi
ch
 th
e 
pr
ac
ti
ti
on
er
s 
ex
pl
ai
ne
d 
th
e 
m
ed
ic
al
 h
is
to
ry
 a
nd
 
po
te
nt
ia
l l
at
e 
ef
fe
ct
s 
to
 
th
e 
su
rv
iv
or
s.
 A
dd
it
io
na
l 
te
st
s 
w
er
e 
co
nd
uc
te
d 
ba
se
d 
on
 th
e 
co
ns
ul
ta
ti
on
. 
Be
si
de
s,
 th
e 
m
ed
ic
al
 d
oc
to
r 
pr
ov
id
ed
 th
e 
co
ns
ul
ta
ti
on
 
su
m
m
ar
ie
s 
an
d 
re
co
m
m
en
-
da
ti
on
s 
ab
ou
t f
ol
lo
w
-u
p 
(r
ec
om
m
en
da
ti
on
 c
ar
d)
 fo
r 
th
e 
su
rv
iv
or
s 
an
d 
th
ei
r G
Ps
. 
Th
e 
m
ed
ic
al
 d
oc
to
r w
ou
ld
 
ca
ll 
th
e 
G
Ps
 if
 th
ey
 d
id
 n
ot
 
re
sp
on
d 
to
 th
e 
st
ud
y 
at
 
fir
st
.
O
ne
 y
ea
r, 
di
ag
-
no
se
d 
as
 p
ri
m
ar
y 
ca
nc
er
 fr
om
 
Ja
nu
ar
y 
19
87
 to
 
D
ec
em
be
r 1
99
2.
A
ll 
ty
pe
s 
of
 
ca
nc
er
 e
xp
ec
t 
le
uk
ae
m
ia
12
0 
su
rv
iv
or
s 
fin
is
he
d 
th
e 
ni
ne
- 
qu
es
ti
on
 s
at
is
fa
ct
io
n 
fo
rm
, 1
07
 o
f t
he
m
 
(8
9%
) w
er
e 
sa
ti
sf
ie
d 
w
it
h 
th
e 
co
ns
ul
ta
-
ti
on
. 8
6%
 o
f t
he
 s
ur
vi
vo
rs
 fo
un
d 
th
e 
re
co
m
m
en
da
ti
on
 c
ar
d 
w
as
 u
se
fu
l. 
M
or
e 
th
an
 7
5%
 fe
lt
 th
ei
r 
lif
es
ty
le
 c
ha
ng
ed
 
su
ch
 a
s 
ph
ys
ic
al
 a
ct
iv
it
y 
an
d 
di
et
s.
 T
yp
e 
of
 c
an
ce
r 
an
d 
tr
ea
tm
en
t w
ou
ld
 in
flu
-
en
ce
 th
e 
sa
ti
sf
ac
ti
on
 w
it
h 
th
e 
fo
llo
w
-u
p 
(p
 <
 0
.0
5)
. T
he
 s
ur
vi
vo
rs
 w
ho
 r
ec
ei
ve
d 
ch
em
ot
he
ra
py
 fe
lt
 m
or
e 
sa
ti
sf
ac
ti
on
 
w
it
h 
th
e 
sh
ar
ed
 c
ar
e 
(p
 =
 0
.0
3)
.
10
6 
G
Ps
 fi
ni
sh
ed
 th
e 
fiv
e 
ar
ea
s 
sa
ti
sf
ac
-
ti
on
 s
ur
ve
y,
 6
3 
of
 th
em
 (5
9%
) r
ep
or
te
d 
th
ey
 w
er
e 
no
t p
ro
vi
de
d 
en
ou
gh
 in
fo
r-
m
at
io
n 
ab
ou
t t
he
 p
at
ie
nt
’s
 tr
ea
tm
en
t, 
82
 o
f t
he
m
 (7
7%
) r
ep
or
te
d 
la
ck
 o
f l
at
e 
ef
fe
ct
 o
f c
he
m
ot
he
ra
py
. B
ut
 m
os
t o
f 
th
em
 fe
lt
 th
e 
re
co
m
m
en
da
ti
on
 c
ar
d 
w
as
 u
se
fu
l (
61
%
), 
ov
er
 8
0%
 o
f t
he
m
 
ap
pr
ec
ia
te
 th
e 
co
lla
bo
ra
ti
on
 a
nd
 a
va
il-
ab
ili
ty
 o
f c
on
ta
ct
 w
it
h 
ho
sp
it
al
.
Th
e 
lo
ng
-t
er
m
 
fo
llo
w
-u
p 
by
 
 co
lla
bo
ra
ti
on
 o
f G
P 
an
d 
ho
sp
it
al
 s
pe
ci
al
-
is
t w
as
 fe
as
ib
le
 
an
d 
co
ul
d 
be
ne
fit
 
ch
ild
ho
od
 c
an
ce
r 
su
rv
iv
or
s 
an
d 
fa
m
ily
 
ph
ys
ic
ia
ns
.
Lu
nd
, e
t a
l. 
[4
1]
, 
20
16
, D
en
m
ar
k
D
es
cr
ip
ti
ve
, 
m
ul
ti
-c
en
tr
e,
 
qu
an
ti
ta
ti
ve
 
53
0 
ca
nc
er
 p
at
ie
nt
s 
fr
om
 th
re
e 
ho
sp
ita
ls
 
w
er
e 
tr
an
sf
er
re
d 
to
 
th
ei
r G
Ps
 a
nd
 in
vi
te
d 
to
 jo
in
 th
e 
sh
ar
ed
 c
ar
e 
fo
llo
w
 u
p 
be
tw
ee
n 
Se
pt
em
be
r 2
01
1 
an
d 
M
ar
ch
 2
01
2,
 th
e 
fo
llo
w
-
up
 la
st
s 
fo
r t
hr
ee
 y
ea
rs
. 
Th
e 
ur
ol
og
ic
al
 s
pe
ci
al
-
is
ts
 d
ev
el
op
ed
 fo
llo
w
-u
p 
re
co
m
m
en
da
ti
on
s 
fo
r 
ev
al
ua
ti
ng
 p
at
ie
nt
 a
nd
 G
P 
co
m
pl
ia
nc
e,
 in
cl
ud
in
g 
th
e 
sc
he
du
le
 o
f f
ol
lo
w
-u
p 
an
d 
th
e 
in
st
ru
ct
io
ns
 o
f r
ef
er
ra
l. 
Th
e 
pa
ti
en
ts
 w
er
e 
tr
an
s-
fe
rr
ed
 to
 th
ei
r G
Ps
.
3 
ye
ar
s,
 w
it
h 
or
 
w
it
ho
ut
 re
la
ps
e
Pr
os
ta
te
 c
an
ce
r
42
6 
(8
0.
8%
) p
at
ie
nt
s 
w
er
e 
an
al
ys
ed
, 
39
0 
pa
ti
en
ts
 (9
1.
5%
) w
er
e 
ra
te
d 
as
 
“a
cc
ep
ta
bl
e”
 o
r 
“g
oo
d”
 c
om
pl
ia
nc
e 
(t
he
 
co
m
pl
ia
nc
e 
w
as
 r
at
ed
 a
s 
fo
ur
 c
ol
um
ns
: 
un
kn
ow
n,
 p
oo
r, 
ac
ce
pt
ab
le
, a
nd
 g
oo
d)
; 
a 
to
ta
l o
f 3
93
 G
P 
(9
2.
3%
) w
er
e 
ra
te
d 
as
 
“g
oo
d”
 o
r 
“a
cc
ep
ta
bl
e”
 c
om
pl
ia
nc
e 
(t
he
 
co
m
pl
ia
nc
e 
w
as
 r
at
ed
 a
s 
fo
ur
 c
ol
um
ns
: 
un
kn
ow
n,
 p
oo
r, 
ac
ce
pt
ab
le
, a
nd
 g
oo
d)
.
Sh
ar
ed
 c
ar
e 
m
od
el
 is
 
a 
sa
fe
 a
pp
ro
ac
h 
w
it
h 
hi
gh
 r
at
e 
of
 p
at
ie
nt
 
an
d 
G
P 
co
m
pl
ia
nc
e
G
P 
= 
ge
ne
ra
l p
ra
ct
it
io
ne
r. 
SC
P:
 s
ur
vi
vo
rs
hi
p 
ca
re
 p
la
n.
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Ta
bl
e 
4
: E
ss
en
ce
 o
f s
ha
re
d 
ca
re
.
A
ut
ho
r,
 y
ea
r,
 
co
un
tr
y
M
aj
or
 
fo
llo
w
-u
p 
ca
re
 
pr
ov
id
er
 in
 
sh
ar
ed
 c
ar
e
O
th
er
 
 fo
llo
w
-u
p 
ca
re
 p
ro
vi
de
r 
in
 s
ha
re
d 
ca
re
 
M
et
ho
d 
of
 s
ha
re
d 
ca
re
 in
vo
lv
em
en
t
N
um
be
r 
of
 fo
rm
al
 
in
te
ra
ct
io
n 
be
tw
ee
n 
di
ff
er
en
t 
ca
re
 
 pr
ov
id
er
s,
 c
om
m
un
i-
ca
ti
on
 t
oo
l b
et
w
ee
n 
ca
re
 p
ro
vi
de
rs
N
um
be
r/
fr
eq
ue
nc
y 
of
 in
te
ra
ct
io
n 
be
tw
ee
n 
pa
ti
en
ts
 
an
d 
pr
im
ar
y 
ca
re
 
in
 in
te
rv
en
ti
on
 
gr
ou
p
N
um
be
r/
 fr
eq
ue
nc
y 
of
 in
te
ra
ct
io
n 
be
tw
ee
n 
pa
ti
en
ts
 
an
d 
pr
im
ar
y 
ca
re
 
in
 c
on
tr
ol
 g
ro
up
D
if
fe
re
nc
e 
be
tw
ee
n 
tw
o 
gr
ou
ps
H
an
an
, e
t a
l. 
[2
9]
, 2
01
4,
 
Ir
el
an
d 
Co
m
m
un
it
y 
nu
rs
es
O
nc
ol
og
y 
 da
y-
w
ar
d 
 nu
rs
es
, 
 sp
ec
ia
lis
t 
 ca
nc
er
 s
ta
ff
Th
e 
sh
ar
ed
 c
ar
e 
in
cl
ud
ed
 a
 s
ix
 m
on
th
s 
sk
ill
s 
tr
ai
ni
ng
 (f
ro
m
 s
pe
ci
al
is
t c
an
ce
r s
ta
ff
) f
or
 c
om
-
m
un
it
y 
nu
rs
es
, s
pe
ci
fic
 re
fe
rr
al
 fo
rm
, a
nd
 p
ro
-
vi
de
d 
ho
sp
it
al
 s
up
po
rt
 fo
r c
om
m
un
it
y 
nu
rs
es
 
in
 u
rg
en
t s
it
ua
ti
on
 b
y 
ph
on
e.
 T
he
 p
at
ie
nt
s 
w
er
e 
to
ld
 th
at
 th
e 
m
ed
ic
al
 o
nc
ol
og
is
ts
 s
ti
ll 
to
ok
 th
e 
re
sp
on
si
bi
lit
y 
of
 th
em
.
M
or
e 
th
an
 o
nc
e,
sk
ill
 tr
ai
ni
ng
, p
ho
ne
, 
an
d 
re
so
ur
ce
 b
oo
k
N
ot
 m
en
ti
on
ed
N
ot
 m
en
ti
on
ed
N
ot
 m
en
ti
on
ed
Be
rg
ho
ld
t, 
et
 a
l. 
[3
1,
 3
2]
, 
20
12
, 2
01
3,
 
D
en
m
ar
k
G
en
er
al
 p
ra
ct
i-
ti
on
er
Tw
o 
ho
sp
it
al
 
nu
rs
es
 w
it
h 
on
co
lo
gi
ca
l 
ex
pe
ri
en
ce
Th
e 
ho
sp
it
al
 n
ur
se
s 
su
gg
es
te
d 
pa
ti
en
ts
 to
 c
on
-
su
lt
 th
ei
r G
Ps
 w
he
n 
ne
ce
ss
ar
y.
 E
qu
al
ly
, t
he
y 
al
so
 
en
co
ur
ag
ed
 th
e 
G
Ps
 to
 b
e 
pr
oa
ct
iv
e 
to
 o
ff
er
 s
up
-
po
rt
 to
 th
ei
r p
at
ie
nt
s,
 a
nd
 s
en
d 
th
e 
G
P 
an
 e
m
ai
l, 
w
hi
ch
 in
cl
ud
e 
th
e 
pa
ti
en
ts
’ i
nf
or
m
at
io
n.
 
O
nc
e,
Em
ai
l a
nd
 p
ho
ne
Pa
ti
en
ts
 r
ep
or
te
d:
 
16
8 
co
nt
ac
ts
 (1
01
 G
P 
pr
oa
ct
iv
e 
co
nt
ac
t, 
61
.1
%
) 
G
P 
re
po
rt
ed
: 
37
9 
co
nt
ac
ts
 (2
32
 
G
P 
pr
oa
ct
iv
e 
co
nt
ac
t, 
61
.2
%
)
Pa
ti
en
ts
 r
ep
or
te
d:
 
15
6 
co
nt
ac
ts
 (8
1 
G
P 
pr
oa
ct
iv
e 
co
nt
ac
t, 
51
.9
%
) G
P 
re
po
rt
ed
: 
37
3 
co
nt
ac
ts
 (2
06
 
G
P 
pr
oa
ct
iv
e 
co
nt
ac
t, 
55
.2
%
)
N
o 
si
gn
ifi
ca
nt
 
di
ff
er
en
ce
s 
in
 b
ot
h 
pa
ti
en
ts
 r
ep
or
te
d 
an
d 
G
P 
re
po
rt
ed
 
co
nt
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Some studies used a descriptive way to assess the satisfac-
tion of survivors and got similar results. First, Blaauwbroek 
et al. found that 88% of the survivors who completed 
the questionnaire were satisfied with the follow-up [36], 
while Berger et al. found a similar result in that 89% of the 
survivors who finished the questionnaire were satisfied 
with the health care [40]. Second, more than 80% of the 
survivors were generally satisfied with the information 
they received in the follow-up in two studies, and 71% 
of the survivors followed the instructions [39, 40]. Third, 
Blaauwbroek et al. reported that survivors were more 
aware of the benefits of follow-up (90.2%), and 73.6% of 
the survivors were more confident with the GPs’ capac-
ity [39]. The only disadvantage of shard care reported in 
all eleven studies was that 15.3% of the childhood cancer 
survivors mentioned that the information they received 
reminded them of the negative memories from the past 
[39]. Finally, the subgroup analysis found that the men 
and younger age group (18–49 years) were significantly 
more satisfied with the shared care and found it easier to 
accept the GPs as their care provider [33], and the diagno-
sis and the treatment could affect the satisfaction with the 
follow-up (p < 0.05) [40].
Care referral and continuity of care
The studies evaluated the continuity of care in different 
aspects, such as the primary care practitioner’s confidence 
in survivorship knowledge, their attitudes toward the 
follow-up and the information they received during the 
follow-up, and the frequency that survivors participated in 
the follow-up, but no significant differences were found 
between the intervention group and control group [32, 
38]. Besides, most studies used descriptive data to report 
the outcomes. Blaauwbroek et al. found that 71.7%–77.4% 
of family doctors reported that their knowledge and abil-
ity of providing follow-up care were improved [39], and 
Lund et al. reported that 91.5%–92.3% could follow the 
follow-up recommendations [41]. Besides, Blaauwbroek 
et al. found that 82% of the family doctors were satisfied 
with the cooperation and the information they received 
[36]. Another study reported that 61% of GPs consid-
ered the information they received and 82% ranked the 
collaboration with hospital as helpful, 59%–77% of the 
general practitioners stated that they received insufficient 
information in different aspects. Furthermore, GPs recom-
mended that specific cancers needed particular follow-up 
more than other cancers such as more GPs considering 
that renal tumour survivors needed more specific care 
than lymphomas survivors (p = 0.013) [40].
The cost of shared care
Only one paper compared the cost of shared care with 
usual care and found that shared care was cheaper than 
usual care [37]. In the Emery et al. study, a multisite ran-
domised controlled trial which included patients of two 
rural and four urban treatment centres was conducted. 
Five routine follow-up visits were carried out in both two 
groups, and two hospital visits were replaced by GP in the 
experimental group. At the end of the research, the shared 
care spent $323 less than usual care for each patient in 
the one-year follow-up.
The care in the shared care group and control group
The interventions were complex. Three trials implemented 
the shared care with a clear division of tasks by hospital 
specialists and primary care physicians [34, 36, 37], while 
the other seven trials implemented the shared care by 
intending to transfer the follow-up care to primary care 
providers smoothly with specified information exchange 
[31–33, 35, 38–41]. The hospital centre and primary care 
formally communicated with each other more than once 
in four out of eleven trials [36–39], but the others only 
involved one formal communication [31–35, 40–41]. The 
cancer survivors in the control group were followed up 
by usual care [31–33, 37] or in the hospital [35] in most 
of the trials. However, one study [38] did not include 
Table 6: Critical review of the quantitative studies with Health Care Practice R&D Unit (HCPRDU).
Question Score
Blaauwbroek, 
et al., 2012 
[39]
Berger,  
et al., 2017 
[40]
Lund,  
et al., 2016 
[41]
(1) Study overview 2 2 1
(2) Study, setting, sample and 
ethics
2 2 1
(3) Ethics 2 0 1
(4) Group comparability and 
outcome measurement
1 1 1
(5) Policy and practice implica-
tions
1 1 2
(6) Other comments 2 1 2
Total score  
(maximum 12)
10 7 8
“0” represents many limitations, “1” represents some limitation, “2” represents excellent.
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survivors in the control group but applied the data from 
another matched study in the same country as the control 
group. Besides, two studies did not clearly describe the 
content of the control group [34, 38].
Discussion
This review included 11 papers that evaluated shared care 
in the continuity of care for cancer survivors. These studies 
conducted shared care with various and complex multifac-
eted interventions for improving the follow-up of cancer 
survivors, especially their quality of life and depression. 
An overview of the results in the selected studies suggests 
that survivors and general practitioners reported favour-
ing shared care, and the survivors who had experienced 
shared care had a stronger preference for shared care in 
the future. However, there were no significant differences 
in terms of quality of life, mental health outcomes, unmet 
needs, and serious clinical events between shared care and 
usual care. One important confounding factor might be 
that the patient-reported results could have been affected 
by the lack of confidence in primary care [42] since it is 
impossible to blind the survivors.
Although only 11 papers were included in the present 
review, the overall sample size and the quality of studies 
constitutes an overview with a preliminary picture of the 
possible way to conduct shared care and the effectiveness 
of shared care. Two models of shared care were identified 
as offering potential to improve the monitoring of cancer 
survivors: the transference of survivors, which lies within 
the information exchange; and the coordination of assess-
ments and treatments, which allows distant health pro-
fessionals to conduct the monitoring alternately. Several 
interventional strategies that were utilised played a role in 
enhancing the efforts in terms of care cooperation: (1) sur-
vivorship care plan; (2) referral and consultation visit; (3) 
improving the knowledge of PCPs; (4) enhancing patient’s 
confidence in health care practitioners, especially in PCPs; 
(5) building the communication channel between health 
care professionals; and (6) the register and recall system.
The studies that assessed the continuity of care found 
that shared care could meet the requirements of follow-
up, and the PCPs felt their knowledge was improved and 
that they had the capability of providing healthcare with 
the support of hospital specialists. Blaauwbroek et al. 
found that 77.4% of the PCPs considered that they had 
the capacity of providing follow-up if the SCP was avail-
able [39], while another survey found that only 40% of 
the PCPs felt confident of their knowledge in the follow-
up of cancer survivors in the usual care [43]. Besides, the 
only study that compared the cost of shared care to usual 
care found that the shared care on average reduced costs 
by $323 per patient at one-year follow-up [37].
Although only those studies that were rated as “good” 
or “excellent” were included in this review, several stud-
ies had major limitations, such as the sample size being 
insufficient [34, 38], the significant differences at the 
baseline [33], and the outcome assessor not being blinded 
in most of the trials. Besides, there were only six RCTs that 
compared shared care with usual care, and many of the 
results were illustrated within a descriptive method. Thus, 
the small number of available studies could not provide a 
solid foundation for this review. Furthermore, there were 
various types of outcomes that were detected in the stud-
ies, so many of the results could not be regrouped based 
on the considerable heterogeneity. Besides, all the stud-
ies were conducted in developed countries, and most of 
the studies were performed in city settings, so the results 
might not apply to other undeveloped countries or rural 
regions. Further limitations include that only papers writ-
ten in English were included and the author appraised the 
papers without blinding to the published journal or the 
writers.
Conclusions
Implications for practice
The present review shines a light on improving the follow-
up, with current evidence indicating that shared care is 
an affordable model as well as being feasible and accept-
able for cancer survivors. It enables GP’s involvement in 
survivorship care and help the cooperation between hos-
pital and primary care. Although the evidence showed 
that the effectiveness of shared care is similar to hospital 
follow-up, the strategies we identified from the included 
studies could be useful to all stakeholders of health care 
and provide a preference for implementing new strategies 
in cancer follow-up to address the sustainable burden of 
hospitals. Due to limited evidence of financial analysis, 
we could not make conclusion that shared care is cheaper 
than usual care, but it is potentially contributing to help 
resolve the stabilised health care costs. However, more 
solid evidence about the effectiveness of shared care is 
needed before it can be routinely implemented.
Implications for research
Although the results of this review do not confirm that 
shared care is more effective than usual care in the 
management of follow-up in cancer survivors, several 
key elements have been identified in shared care: the 
consultation meeting, the formal transferring of docu-
ments, encouraging communication between the survi-
vors and the practitioners, and the length of follow-up. 
Besides, the communication channel and register and 
recall system are also considered as important elements 
in shared care. The research gaps of the included stud-
ies also indicate the directions that future studies need 
to address. First, further RCTs with sufficient sample size 
are needed to explore the health-related cost of shared 
care and the clinical outcomes. Second, the differences in 
the  subgroup indicate that individual follow-up should 
be conducted based on the diagnosis, treatment, age, and 
gender. Third, the follow up should be modified accord-
ing to the specific health care needs in different time 
frames since diagnosis [44].
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